Gaithersburg biotech Salubris Biotherapeutics clinches $35M investment for R&D


The capital brings the local company's lifetime funding to more than $100 million.

Previous Silicon Valley Bank lost $63B in deposits in the 2 weeks after it was seized
Next Philadelphia 76ers select Lokal Artisan Foods as 2023 Buy Black Program winner